Background
Commission Implementing Decision (EU) 2019/1396 originally established expert panels to advise on high-risk medical devices under the Medical Devices Regulation (MDR), article 106(1). Since its entry into force, key developments triggered the need for amendment, especially experience revealed a gap in advice for paediatric and rare-disease device needs.
Purpose of Implementing Decision (EU) 2025/1324
Adopted 7 July 2025 and effective 28 July 2025, it amends 2019/1396 to:
- Designate a new panel for medical devices and IVD medical devices targeting paediatric and rare-disease populations.
- Streamline administration by allowing temporary assignment of advisors across panels, enabling permanent or ad hoc sub-groups, clarifying roles for rapporteurs and reviewers, mandating public rules of procedure, and standardizing timelines and expert remuneration.
Source: European Commission